Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S5W-33477 · Session 5

Whether it is aware of any evidence or studies that indicate that the use of antipsychotic drugs in older people can suppress their immune …

Answered Asked by Miles Briggs Con Lodged 23 Nov 2020

The question

To ask the Scottish Government whether it is aware of any evidence or studies that indicate that the use of antipsychotic drugs in older people can suppress their immune system.

The answer

Answered by Clare Haughey on 3 Dec 2020 · 10 days after it was lodged, on time

Clinical staff will always make individual clinical decisions and will assessments on prescribing antipsychotic medication based on patient risk factors, benefits and existing conditions.
The Scottish Government’s Standards of Care for Dementia set out standards for the prescribing, use and review of psychoactive medications across all care settings. Such medication should be prescribed following appropriate individual clinical assessment and consultation with families and only after all other alternatives, including therapeutic interventions, have been explored.
The risk of blood disorders (leukopenia/neutropenia/agranulocytosis) which involve a reduction in the number of white blood cells involved in the immune response is a recognised adverse drug reaction for antipsychotic medicines. A reduction of these blood cells can lead to an impaired immune response and an increased risk of infection. The risk of blood disorders when using antipsychotic medicines applies to all patients taking these medicines regardless of their age.
A list of the recognised side effects for every antipsychotic medicine is provided in the product information which accompanies the medicine. This includes the product’s Summary of Product Characteristics for healthcare professionals and a Patient Information Leaflet. The product information for each antipsychotic medicine can be found on the electronic Medicines Compendium website at www.emc.medicines.org.uk .

In the Official Report

No contribution in the Official Report cites S5W-33477 by reference.